Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost for scalp patchy alopecia areata
IRCT20090813002342N11Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in alopecia areata comparing Clobetasol + latanoprost with Clobetasol + placebo (2 arms). Primary endpoint: Area of scalp with hair loss at 3 months. Started Jun 2018; status: completed.
02
Drugs
latanoprostclobetasol
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20090813002342N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090813002342N11.